Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
49,124,220
-
Share change
-
+280,845
-
Total reported value
-
$908,712,891
-
Price per share
-
$18.50
-
Number of holders
-
151
-
Value change
-
+$8,384,641
-
Number of buys
-
91
-
Number of sells
-
43
Institutional Holders of DECIPHERA PHARMACEUTICALS IN - COM (DCPH) as of Q3 2022
As of 30 Sep 2022,
DECIPHERA PHARMACEUTICALS IN - COM (DCPH) was held by
151 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
49,124,220 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, ARMISTICE CAPITAL, LLC, GOLDMAN SACHS GROUP INC, STATE STREET CORP, Redmile Group, LLC, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), Assenagon Asset Management S.A., JACOBS LEVY EQUITY MANAGEMENT, INC, and Polar Capital Holdings Plc.
This page lists
151
institutional shareholders reporting positions in this security
for the Q3 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.